MiR-205 as Predictive Biomarker and Adjuvant Therapeutic Tool in Combination With Trastuzumab

Oncotarget - United States
doi 10.18632/oncotarget.24723
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

MiR-205 as a Promising Biomarker in the Diagnosis and Prognosis of Lung Cancer

Oncotarget
Oncology
2017English

Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells

PLoS ONE
Multidisciplinary
2012English

Predictive Value of miR-9 as a Potential Biomarker for Nasopharyngeal Carcinoma Metastasis

British Journal of Cancer
Cancer ResearchOncology
2013English

Combination of Three miRNA (miR-141, miR-21, and miR-375) as Potential Diagnostic Tool for Prostate Cancer Recognition

International Urology and Nephrology
UrologyNephrology
2018English

Integrative Bioinformatics Analysis Reveals miR-494 and Its Target Genes as Predictive Biomarkers of Trastuzumab-Resistant Breast Cancer

Journal of the Egyptian National Cancer Institute
2020English

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Journal of Oncology
Oncology
2018English

TRAP1 Is a Predictive Biomarker of Platinum-Based Adjuvant Chemotherapy Benefits in Patients With Resected Lung Adenocarcinoma

Biomedical Research
BiochemistryMedicineGeneticsMolecular Biology
2020English

Serum microRNA-205 as a Novel Biomarker for Cervical Cancer Patients

Cancer Cell International
Cancer ResearchOncologyGenetics
2014English

sCLU as Prognostic Biomarker and Therapeutic Target in Osteosarcoma

Bioengineered
Applied MicrobiologyBiotechnologyMedicineBioengineering
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy